Clinical Trials | Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)
Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET) [AIDANET AI]
The Center for Diabetes Technology seeks adults ages 18 and older with Type 1 Diabetes for a research study. The purpose of this study is to find out if a system called AIDANET AI (Automated Insulin Delivery Adaptive NETwork Artificial Intelligence) is safe and can help control blood sugar better for people with Type 1 Diabetes. The study involves wearing study equipment to manage your diabetes for about 9 weeks. There will be 12 study visits with most of the visits completed by telephone or virtually from home. You may need to attend an in-person training visit to learn how to use the Tandem Mobi insulin pump, a Dexcom continuous glucose monitor (CGM), and the investigational AIDANET system. Study-related equipment and supplies are provided at no cost to you. You will need to use your own insulin. For more information, please contact the study coordinator, Carlene Alix at [email protected] or 434-249-8961.